Strategic partnerships IDBS is a Danaher company with a long track record in biopharma, partnering with 80% of the top 20 global Biopharma companies. This indicates strong channel and co-sell opportunities with a proven ecosystem that can be leveraged to expand into additional customers or geographies.

Cloud platform expansion With flagship offerings like E-WorkBook, Polar, and PIMS now in cloud form, there is a clear up-sell path to customers migrating to cloud-based data management and analytics. Emphasize integrated workflows, GxP compliance, and scalable data capabilities to capture new ARR.

AI/ML focus IDBS highlights AI/ML-enabled data context and insights across R&D to manufacturing. This presents a cross-sell opportunity for AI-driven experimentation, predictive analytics, and automation services to biopharma customers looking to accelerate development timelines.

Recent awards and wins Awards for software innovation in biologics digitalisation and recent collaborations signal credibility and market momentum. Leverage these successes in outreach to highlight proven value, case studies, and risk reduction for prospective customers.

Expansion and events Active participation in industry events (i3 2026, ABEA awards) and partnerships (Alchemi, Vantive Health) indicate ongoing market engagement. This creates opportunities for targeted trials, executive briefings, and introductions to decision-makers during forums.